Engraftment Syndrome after Autologous Stem Cell Transplantation: An Update Unifying the Definition and Management Approach.

[1]  D. Seldin,et al.  Induction Therapy with Bortezomib Followed by Bortezomib-High Dose Melphalan and Stem Cell Transplantation for Light Chain Amyloidosis: Results of a Prospective Clinical Trial. , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[2]  R. Gale,et al.  Engraftment syndrome, the Emperor’s new clothes and the artist formerly known as prince , 2015, Bone Marrow Transplantation.

[3]  J. Wagner,et al.  Comparison of Engraftment Syndrome with G-CSF Versus GM-CSF after Autologous Hematopoietic Progenitor Cell Transplantation for Multiple Myeloma , 2015 .

[4]  T. Spitzer,et al.  Engraftment syndrome: double-edged sword of hematopoietic cell transplants , 2015, Bone Marrow Transplantation.

[5]  R. Gale,et al.  Autologous GVHD? , 2014, Bone Marrow Transplantation.

[6]  J. Ritz,et al.  Current issues in chronic graft-versus-host disease. , 2014, Blood.

[7]  P. Hari,et al.  Divergent effects of novel immunomodulatory agents and cyclophosphamide on the risk of engraftment syndrome after autologous peripheral blood stem cell transplantation for multiple myeloma. , 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[8]  G. Elgart,et al.  Elafin: a possible new biomarker and immunohistochemical stain for pre-engraftment syndrome. , 2013, Journal of American Academy of Dermatology.

[9]  F. Costa,et al.  Post-autologous hematopoietic SCT engraftment syndrome:a single center experience , 2012, Bone Marrow Transplantation.

[10]  D. Dingli,et al.  Acute kidney injury during leukocyte engraftment after autologous stem cell transplantation in patients with light‐chain amyloidosis , 2012, American journal of hematology.

[11]  S. Trudel,et al.  Cyclophosphamide and prednisone induction followed by cyclophosphamide mobilization effectively decreases the incidence of engraftment syndrome in patients with POEMS syndrome who undergo stem cell transplantation , 2011, American journal of hematology.

[12]  P. Fu,et al.  Spontaneous autologous graft-versus-host disease in plasma cell myeloma autograft recipients: flow cytometric analysis of hematopoietic progenitor cell grafts. , 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[13]  R. Komorowski,et al.  Gastrointestinal pathology of autologous graft-versus-host disease following hematopoietic stem cell transplantation: a clinicopathological study of 17 cases , 2011, Modern Pathology.

[14]  D. Hurd,et al.  Possible role of engraftment syndrome and autologous graft-versus-host disease in myelodysplastic syndrome after autologous stem cell transplantations: retrospective analysis and review of the literature. , 2010, Clinical lymphoma, myeloma & leukemia.

[15]  B. Ruben,et al.  A case of severe cutaneous, GI and liver GVHD in a patient with multiple myeloma, status-post-second auto-SCT , 2010, Bone Marrow Transplantation.

[16]  M. Lozano,et al.  Engraftment syndrome after auto-SCT: analysis of diagnostic criteria and risk factors in a large series from a single center , 2010, Bone Marrow Transplantation.

[17]  K. Washington,et al.  Pathology of graft-versus-host disease in the gastrointestinal tract. , 2009, Human pathology.

[18]  P. Hari,et al.  Severe autologous GVHD after hematopoietic progenitor cell transplantation for multiple myeloma , 2009, Bone Marrow Transplantation.

[19]  A. Dalgleish,et al.  The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells , 2009, Cancer Immunology, Immunotherapy.

[20]  D. Dingli,et al.  Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome , 2008, European journal of haematology.

[21]  G. Ayers,et al.  Endoscopic Biopsy Diagnosis of Acute Gastrointestinal Graft-Versus-Host Disease: Rectosigmoid Biopsies Are More Sensitive Than Upper Gastrointestinal Biopsies , 2008, The American Journal of Gastroenterology.

[22]  I. Flinn,et al.  Induction of autologous graft-versus-host disease: results of a randomized prospective clinical trial in patients with poor risk lymphoma. , 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[23]  R. Schlenk,et al.  Autologous graft-versus-host disease-like syndrome after an alemtuzumab-containing conditioning regimen and autologous stem cell transplantation for chronic lymphocytic leukemia. , 2006, Blood.

[24]  S. Jagannath,et al.  Engraftment syndrome after hematopoietic stem cell transplantation in multiple myeloma. , 2006, Clinical Lymphoma & Myeloma.

[25]  A. Noffsinger,et al.  Severe intestinal graft-versus-host disease following autologous stem cell transplantation , 2006, Bone Marrow Transplantation.

[26]  K. Rezvani,et al.  High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT. , 2006, Blood.

[27]  K. Tarte,et al.  Functional Regulatory T Cells Are Collected in Stem Cell Autografts by Mobilization with High-Dose Cyclophosphamide and Granulocyte Colony-Stimulating Factor1 , 2006, The Journal of Immunology.

[28]  D. Hockenbery,et al.  Gastrointestinal graft-versus-host disease in recipients of autologous hematopoietic stem cells: incidence, risk factors, and outcome. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[29]  B. Barlogie,et al.  Serial measurement of serum C-reactive protein levels can identify patients at risk for severe complications following autologous stem cell transplantation , 2005, Leukemia & lymphoma.

[30]  S. Fernandez,et al.  Engraftment syndrome after autologous peripheral blood progenitor cell transplantation in pediatric patients: a prospective evaluation of risk factors and outcome , 2004, Bone Marrow Transplantation.

[31]  L. Madero,et al.  Engraftment Syndrome Emerges as the Main Cause of Transplant-Related Mortality in Pediatric Patients Receiving Autologous Peripheral Blood Progenitor Cell Transplantation , 2004, Journal of pediatric hematology/oncology.

[32]  H. Deeg,et al.  Acute Graft-vs-Host Disease , 2004 .

[33]  Â. Maiolino,et al.  Engraftment syndrome following autologous hematopoietic stem cell transplantation: definition of diagnostic criteria , 2003, Bone Marrow Transplantation.

[34]  E. Montserrat,et al.  CD34+ selected autologous peripheral blood stem cell transplantation for multiple sclerosis: report of toxicity and treatment results at one year of follow-up in 15 patients. , 2003, Haematologica.

[35]  D. Eastwood,et al.  Engraftment syndrome after autologous hematopoietic stem cell transplant supported by granulocyte-colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor (GM-CSF) , 2003, Bone Marrow Transplantation.

[36]  B. Pollock,et al.  Engraftment syndrome in breast cancer patients after stem cell transplantation is associated with poor long-term survival. , 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[37]  A. Tefferi,et al.  Peri-engraftment respiratory distress syndrome during autologous hematopoietic stem cell transplantation , 2001, Bone Marrow Transplantation.

[38]  T. Spitzer.  Engraftment syndrome following hematopoietic stem cell transplantation , 2001, Bone Marrow Transplantation.

[39]  G. Goodwin,et al.  An engraftment syndrome in autologous stem cell transplantation related to mononuclear cell dose , 2000, Bone Marrow Transplantation.

[40]  A. Hess,et al.  Autologous graft-versus-host disease , 1995, Journal of hematotherapy & stem cell research.

[41]  M. Björkholm,et al.  Immune reconstitution after autologous hematopoietic stem cell transplantation in relation to underlying disease, type of high-dose therapy and infectious complications. , 2000, Haematologica.

[42]  N. Russell,et al.  Autologous GVHD following PBSCT, with evidence for a graft-versus-myeloma effect , 1997, Bone Marrow Transplantation.

[43]  C. Thoburn,et al.  Specificity of effector T lymphocytes in autologous graft-versus-host disease: role of the major histocompatibility complex class II invariant chain peptide. , 1997, Blood.

[44]  B. Andersson,et al.  Phase I trial of cyclosporine-induced autologous graft-versus-host disease in patients with multiple myeloma undergoing high-dose chemotherapy with autologous stem-cell rescue. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[45]  P. Kubilis,et al.  Increased frequency of autoaggression syndrome associated with autologous stem cell transplantation in breast cancer patients , 1997, Bone Marrow Transplantation.

[46]  A. Delannoy,et al.  Clinical evidence for an engraftment syndrome associated with early and steep neutrophil recovery after autologous blood stem cell transplantation. , 1996, Bone marrow transplantation.

[47]  T. Spitzer,et al.  Marrow engraftment and clinical manifestations of capillary leak syndrome. , 1996, Bone marrow transplantation.

[48]  J. Thompson,et al.  Close simulation of acute graft-versus-host disease by interleukin-2 administered after autologous bone marrow transplantation for hematologic malignancy. , 1996, Bone marrow transplantation.

[49]  R. Gingrich,et al.  Engraftment syndrome in autologous bone marrow and peripheral stem cell transplantation. , 1995, Bone marrow transplantation.

[50]  A. Hess,et al.  Characterization of the autoreactive T cell repertoire in cyclosporin-induced syngeneic graft-versus-host disease. A highly conserved repertoire mediates autoaggression. , 1995, Journal of immunology.

[51]  G. Somlo,et al.  Skin biopsy in allogeneic and autologous bone marrow transplant patients: a histologic and immunohistochemical study and review of the literature. , 1995, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[52]  E. Abella,et al.  Phase I study of alpha-interferon augmentation of cyclosporine-induced graft versus host disease in recipients of autologous bone marrow transplantation. , 1994, Bone marrow transplantation.

[53]  N. Davidson,et al.  Phase I trial of interferon gamma to potentiate cyclosporine-induced graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[54]  E. Fuchs,et al.  Cyclosporine-induced syngeneic graft-vs-host disease: prevention of autoaggression by treatment with monoclonal antibodies to T lymphocyte cell surface determinants and to MHC class II antigens. , 1993, Clinical Immunology and Immunopathology.

[55]  R. Beveridge,et al.  Phase I trial of intravenous cyclosporine to induce graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[56]  E. Farmer,et al.  Cyclosporine-induced graft-versus-host disease after autologous bone marrow transplantation for acute myeloid leukemia. , 1993, Leukemia & lymphoma.

[57]  G. Gahrton,et al.  Bone marrow transplantation for acute myeloid leukemia : the EBMT experience. A prospective analysis from HLA-typing , 1992 .

[58]  M. Sykes.  Dissociating graft-vs-host disease from the graft-vs-leukemia effect of allogeneic T cells: the potential role of IL-2. , 1992, Bone marrow transplantation.

[59]  M. Jadus,et al.  The role of cytokines in graft-versus-host reactions and disease. , 1992, Bone marrow transplantation.

[60]  A. Hess,et al.  Effector mechanisms in cyclosporine A-induced syngeneic graft-versus-host disease. Role of CD4+ and CD8+ T lymphocyte subsets. , 1990, Journal of immunology.

[61]  A. Hess,et al.  Host resistance to cyclosporine induced syngeneic graft-versus-host disease. Requirement for two distinct lymphocyte subsets. , 1989, Journal of immunology.

[62]  S. Piantadosi,et al.  INDUCTION OF GRAFT-VERSUS-HOST DISEASE AFTER AUTOLOGOUS BONE MARROW TRANSPLANTATION , 1989, The Lancet.

[63]  R. Schwartz,et al.  Effects of cyclosporine A on T cell development and clonal deletion. , 1988, Science.

[64]  S. Berkowitz,et al.  Graft-versus-leukemia in the rat--the antileukemic efficacy of syngeneic and allogeneic graft-versus-host disease. , 1987, Transplantation Proceedings.

[65]  E. Farmer,et al.  Acute graft-vs-host disease. Development following autologous and syngeneic bone marrow transplantation. , 1987, Archives of dermatology.

[66]  A. Hess,et al.  Development of graft-vs.-host disease-like syndrome in cyclosporine- treated rats after syngeneic bone marrow transplantation. I. Development of cytotoxic T lymphocytes with apparent polyclonal anti-Ia specificity, including autoreactivity , 1985, The Journal of experimental medicine.

[67]  E. Farmer,et al.  Graft-versus-host disease in cyclosporin A-treated rats after syngeneic and autologous bone marrow reconstitution , 1983, The Journal of experimental medicine.

[68]  E. Reinherz,et al.  Abnormalities of immunoregulatory T cells in disorders of immune function. , 1979, The New England journal of medicine.

[69]  J. Loutit,et al.  ACUTE GRAFT-VERSUS-HOST DISEASE IN RECIPIENTS OF BONE-MARROW TRANSPLANTS FROM IDENTICAL TWIN DONORS , 1979, The Lancet.

[70]  J. Lawrence,et al.  VENTRICULAR FIBRILLATION AFTER NARCOTIC WITHDRAWAL , 1975, The Lancet.

[71]  D. Hadden,et al.  DOES T4-TOXICOSIS EXIST ? , 1975, The Lancet.

[72]  R. Slavin,et al.  The graft versus host reaction in man after bone marrow transplantation: pathology, pathogenesis, clinical features, and implication. , 1973, Clinical immunology and immunopathology.